Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119023) titled 'A study on the impact of pan-immune inflammation values on the clinical prognosis of heart failure patients with different ejection fractions' on Feb. 14.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: The First Central Hospital of Tianjin
Condition:
heart failure
Intervention:
HFpEF group:none.
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-07-25
Target Sample Size: HFpEF group:400;HFrEF+HFmrEF group:400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=304519
Disclaimer: Curated by HT Syndicatio...